ROCHE DIAGNOSTICS POSITIONED TO SERVE PUBLIC HEALTH LABS HEIGHTENED CONCERNS over bioterrorist attacks have accelerated plans within the public health lab sector to acquire state-of-the art diagnostic technology in DNA typing and enzyme immunoassay. Roche Diagnostics has instrument systems well-suited for both testing categories. Its DNA analyzers will compete with systems from Applied Biosystems and […]
To access this post, you must purchase The Dark Report.